30
https://pubmed.ncbi.nlm.nih.gov/38091904
Chronic intermittent, targeted delivery of the anti-seizure drug vigabatrin to the subthalamic nucleus in rats shows potential for treating drug-resistant epilepsy, although tolerance to the drug still develops over time.